Beate Hauptrock
Mainz, RP, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Remission induction versus immediate allogeneic haematopoietic stem cell transplantation for patients with relapsed or poor responsive acute myeloid leukaemia (ASAP): a randomised, open-label, phase 3, non-inferiority trial.
Journal: The Lancet. Haematology
Published: January 08, 2024
Prevention of CMV/EBV reactivation by double-specific T cells in patients after allogeneic stem cell transplantation: results from the randomized phase I/IIa MULTIVIR-01 study.
Journal: Frontiers in immunology
Published: July 02, 2023
Diagnosis of sinusoidal obstruction syndrome: can biopsy be the key?
Journal: Annals of hematology
Published: January 25, 2023
Alloimmune Myositis as Paraneoplastic Complication of an Oral Squamous Cell Carcinoma After Severe Chronic Graft vs Host Disease or a Manifestation of Chronic Graft vs Host Disease? A Case Report and Literature Discussion.
Journal: Transplantation proceedings
Published: September 16, 2020
Prognostic factors and outcome of adult allogeneic hematopoietic stem cell transplantation patients admitted to intensive care unit during transplant hospitalization.
Journal: Scientific reports
Published: June 07, 2019
Treosulfan or busulfan plus fludarabine as conditioning treatment before allogeneic haemopoietic stem cell transplantation for older patients with acute myeloid leukaemia or myelodysplastic syndrome (MC-FludT.14/L): a randomised, non-inferiority, phase 3 trial.
Journal: The Lancet. Haematology
Published: March 13, 2019
A Potent Tumor-Reactive p53-Specific Single-Chain TCR without On- or Off-Target Autoimmunity In Vivo.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: June 28, 2018
Showing 1-9 of 9
Last Updated: 09/26/2026